152 related articles for article (PubMed ID: 34316408)
1. Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer.
Chen J; Li L; Sun L; Yuan Y; Jing J
PeerJ; 2021; 9():e11791. PubMed ID: 34316408
[TBL] [Abstract][Full Text] [Related]
2. Epistatic SNP interaction of ERCC6 with ERCC8 and their joint protein expression contribute to gastric cancer/atrophic gastritis risk.
Jing JJ; Lu YZ; Sun LP; Liu JW; Gong YH; Xu Q; Dong NN; Yuan Y
Oncotarget; 2017 Jun; 8(26):43140-43152. PubMed ID: 28562347
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer.
Luo SS; Liao XW; Zhu XD
Biomed Res Int; 2018; 2018():6204684. PubMed ID: 30417012
[TBL] [Abstract][Full Text] [Related]
4. Integrative genomic analysis implicates ERCC6 and its interaction with ERCC8 in susceptibility to breast cancer.
Moslehi R; Tsao HS; Zeinomar N; Stagnar C; Fitzpatrick S; Dzutsev A
Sci Rep; 2020 Dec; 10(1):21276. PubMed ID: 33277540
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation signatures associated with prognosis of gastric cancer.
Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
[TBL] [Abstract][Full Text] [Related]
6. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
[TBL] [Abstract][Full Text] [Related]
7. Elevated limb-bud and heart development (LBH) expression indicates poor prognosis and promotes gastric cancer cell proliferation and invasion via upregulating Integrin/FAK/Akt pathway.
Yu R; Li Z; Zhang C; Song H; Deng M; Sun L; Xu L; Che X; Hu X; Qu X; Liu Y; Zhang Y
PeerJ; 2019; 7():e6885. PubMed ID: 31119084
[TBL] [Abstract][Full Text] [Related]
8. Profiling and Integrated Analysis of the
Wang Y; Zhang G; Li P; Kang L; Qin B; Cao Y; Luo J; Chen X; Qin M; Guan H
Curr Eye Res; 2021 Sep; 46(9):1341-1352. PubMed ID: 33632032
[No Abstract] [Full Text] [Related]
9. Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer.
Chu XD; Lin ZB; Huang T; Ding H; Zhang YR; Zhao Z; Huangfu SC; Qiu SH; Guo YG; Chu XL; Pan JH; Pan YL
BMC Cancer; 2022 Mar; 22(1):250. PubMed ID: 35255858
[TBL] [Abstract][Full Text] [Related]
10. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H
Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548
[TBL] [Abstract][Full Text] [Related]
11. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
12. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
13. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Gastric Carcinoma using Bioinformatics Analysis.
Yang G; Zhang Y; Yang J
Med Sci Monit; 2019 Nov; 25():8777-8796. PubMed ID: 31747387
[TBL] [Abstract][Full Text] [Related]
14. First molecular study in Lebanese patients with Cockayne syndrome and report of a novel mutation in ERCC8 gene.
Chebly A; Corbani S; Abou Ghoch J; Mehawej C; Megarbane A; Chouery E
BMC Med Genet; 2018 Sep; 19(1):161. PubMed ID: 30200888
[TBL] [Abstract][Full Text] [Related]
15. Identification of critical genes in gastric cancer to predict prognosis using bioinformatics analysis methods.
Liu J; Ma L; Chen Z; Song Y; Gu T; Liu X; Zhao H; Yao N
Ann Transl Med; 2020 Jul; 8(14):884. PubMed ID: 32793728
[TBL] [Abstract][Full Text] [Related]
16. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
17. Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression.
Feng H; Jin Z; Liu K; Peng Y; Jiang S; Wang C; Hu J; Shen X; Qiu W; Cheng X; Zhao R
J Cell Mol Med; 2020 Nov; 24(21):12667-12680. PubMed ID: 32939931
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
19. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
20. Development and verification of a microsatellite instability-related risk signature for predicting survival and therapy effectiveness in gastric cancer.
Zhang T; Yu S; Zhao S
J Gastrointest Oncol; 2022 Feb; 13(1):84-101. PubMed ID: 35284118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
